3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
7
Small Cell Lung Carcinoma
6
Fallopian Tube Neoplasms
4
Lung Neoplasms
3
Sarcoma, Ewing
2
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Uterine Cervical Neoplasms
1
SCLC
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
Cyclophosphamide
4
Etoposide
2
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Whole-Body Irradiation
1
Vincristine
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Doxorubicin
1
Disulfides
1
Cyclosporine
1
CTLA-4 Antigen
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Topotecan
×
30 days
×
Clear all
No trials found.